SK

Sayed Kamran Farazuddin

Active Director Director/Designated Partner DIN 11938844
DIN 11938844 First appointment Oct 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sayed Kamran Farazuddin

Sayed Kamran Farazuddin is a Director/Designated Partner at Glycordis Healthcare Private Limited (since 2026).

DIN 11938844
Primary Designation Director/Designated Partner
First Appointment 05 Oct 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glycordis Healthcare Private Limited U86909TS2026PTC222529
Director/Designated Partner05 Oct 20262026Active

Board colleagues of Sayed Kamran Farazuddin

NameDINCompanyDesignation
Shamaila Sameen11938845Glycordis Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glycordis Healthcare Private Limited
Premium access

Shareholding and investment profile for Sayed Kamran Farazuddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayed Kamran Farazuddin

Sayed Kamran Farazuddin currently holds 1 directorship: Glycordis Healthcare Private Limited (Director/Designated Partner, since 05 Oct 2026).

Sayed Kamran Farazuddin was first appointed on 05 Oct 2026 as Director/Designated Partner at Glycordis Healthcare Private Limited.

The current boards of Sayed Kamran Farazuddin's companies include Shamaila Sameen (Glycordis Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available